PHARMA EVIDENCE ApS: Financial statements 2017
CVR: 34586519
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 625,347 and a net result of DKK 279,719 compared with DKK -47,525 the year before. Equity in the 2017 report amounted to DKK 305,566. The solvency ratio was 53.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 625,347
- Profit/Loss
- DKK 279,719
- Equity
- DKK 305,566
- Total Assets
- DKK 573,964
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 625 t. | 280 t. | 306 t. | 1 |
| 2016 | - | -28 t. | -48 t. | 26 t. | - |
| 2015 | - | 255 t. | -154 t. | 73 t. | - |
| 2014 | - | 1.3 mio. | -237 t. | 227 t. | - |
| 2013 | - | 892 t. | 54 t. | 464 t. | - |
Official annual report
Keep an eye on PHARMA EVIDENCE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PHARMA EVIDENCE ApS has published its annual report for 2016. Gross profit came to DKK -28,318, and the net result was DKK -47,525.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.